Although SHP-1 was demonstrated to be a negative regulator of proliferation, knockdown of SHP-1 resulted in CDK6 downregulation and G1/S cell cycle arrest in prostate cancer cells (20,29). This evidence concerns the gene NR0B2 and prostate carcinoma.